Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate Cancer
Document Type
Journal Article
Publication Date
2020
Journal
International Journal of Radiation Oncology-Biology-Physics
DOI
10.1016/j.ijrobp.2019.11.418
APA Citation
Lin, J., Den, R. B., Greenspan, J., Showalter, T. N., Hoffman-Censits, J. H., Lallas, C. D., Trabulsi, E. J., Gomella, L. G., Hurwitz, M. D., Leiby, B., Dicker, A. P., & Kelly, W. K. (2020). Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate Cancer. International Journal of Radiation Oncology-Biology-Physics, (). http://dx.doi.org/10.1016/j.ijrobp.2019.11.418
Peer Reviewed
1
